P1 · PANEL / ROI / AXIS GROUND TRUTH
原 EXE 对齐基准真值复核
所有保存均写入追加式审计事件;旧标注、旧比较和旧提取结果不会被删除或覆盖。
simple_two_curve
pending
PMID 41424028
First-line atezolizumab monotherapy vs . single-agent chemotherapy in patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum-based therapy: Analysis of the IPSOS Asian subpopulation.
F1 · Panel OS · Overall survival
Figure 1 OS in the IPSOS Asian subpopulation by treatment arm (atezolizumab vs. chemotherapy) at data cutoff (April 30, 2022). Atezo: Atezolizumab; Chemo: Chemotherapy; CI: Confidence interval; HR: Hazard ratio; mo: Months; mOS: Median overall survival; No.: Number; OS: Overall survival.坐标框复核
洋红 = 当前 Linux 候选;绿色 = 已保存人工真值。没有绿色框表示仍未形成真值。
当前候选 {'x0': 120, 'y0': 6, 'x1': 628, 'y1': 314}
人工真值 {'x0': 120, 'x1': 628, 'y0': 6, 'y1': 314}
查看候选 OCR 与警告(只能作种子,不能自证真值)
{
"complete": true,
"engine": "RapidOCR",
"plot_bottom": 313,
"plot_left": 120,
"plot_right": 627,
"plot_top": 6,
"warnings": [],
"x_axis_y": 312,
"x_confidence": 0.99,
"x_detected": true,
"x_max": 54,
"x_min": 0,
"x_ticks": [
{
"box": [
[
116.0,
321.0
],
[
127.0,
321.0
],
[
127.0,
335.0
],
[
116.0,
335.0
]
],
"confidence": 0.9029554724693298,
"pixel": 121.5,
"text": "0",
"value": 0.0
},
{
"box": [
[
170.0,
321.0
],
[
181.0,
321.0
],
[
181.0,
336.0
],
[
170.0,
336.0
]
],
"confidence": 0.997306227684021,
"pixel": 175.5,
"text": "6",
"value": 6.0
},
{
"box": [
[
221.0,
320.0
],
[
243.0,
320.0
],
[
243.0,
338.0
],
[
221.0,
338.0
]
],
"confidence": 0.9996743202209473,
"pixel": 232.0,
"text": "12",
"value": 12.0
},
{
"box": [
[
277.0,
320.0
],
[
299.0,
320.0
],
[
299.0,
338.0
],
[
277.0,
338.0
]
],
"confidence": 0.9992391765117645,
"pixel": 288.0,
"text": "18",
"value": 18.0
},
{
"box": [
[
333.0,
320.0
],
[
356.0,
320.0
],
[
356.0,
338.0
],
[
333.0,
338.0
]
],
"confidence": 0.999759316444397,
"pixel": 344.5,
"text": "24",
"value": 24.0
},
{
"box": [
[
390.0,
320.0
],
[
413.0,
320.0
],
[
413.0,
338.0
],
[
390.0,
338.0
]
],
"confidence": 0.9994873404502869,
"pixel": 401.5,
"text": "30",
"value": 30.0
},
{
"box": [
[
447.0,
320.0
],
[
469.0,
320.0
],
[
469.0,
338.0
],
[
447.0,
338.0
]
],
"confidence": 0.9997129738330841,
"pixel": 458.0,
"text": "36",
"value": 36.0
},
{
"box": [
[
502.0,
319.0
],
[
526.0,
319.0
],
[
526.0,
338.0
],
[
502.0,
338.0
]
],
"confidence": 0.9996476769447327,
"pixel": 514.0,
"text": "42",
"value": 42.0
},
{
"box": [
[
559.0,
320.0
],
[
582.0,
320.0
],
[
582.0,
338.0
],
[
559.0,
338.0
]
],
"confidence": 0.9996607303619385,
"pixel": 570.5,
"text": "48",
"value": 48.0
},
{
"box": [
[
616.0,
320.0
],
[
638.0,
320.0
],
[
638.0,
338.0
],
[
616.0,
338.0
]
],
"confidence": 0.9998516738414764,
"pixel": 627.0,
"text": "54",
"value": 54.0
}
],
"y_axis_x": 122,
"y_confidence": 0.999,
"y_detected": true,
"y_max": 100,
"y_min": 0,
"y_ticks": [
{
"box": [
[
89.0,
58.0
],
[
112.0,
58.0
],
[
112.0,
76.0
],
[
89.0,
76.0
]
],
"confidence": 0.9991725087165833,
"pixel": 67.0,
"text": "80",
"value": 80.0
},
{
"box": [
[
89.0,
120.0
],
[
112.0,
120.0
],
[
112.0,
138.0
],
[
89.0,
138.0
]
],
"confidence": 0.9991351664066315,
"pixel": 129.0,
"text": "60",
"value": 60.0
},
{
"box": [
[
89.0,
181.0
],
[
112.0,
181.0
],
[
112.0,
199.0
],
[
89.0,
199.0
]
],
"confidence": 0.9995252788066864,
"pixel": 190.0,
"text": "40",
"value": 40.0
},
{
"box": [
[
89.0,
243.0
],
[
112.0,
243.0
],
[
112.0,
260.0
],
[
89.0,
260.0
]
],
"confidence": 0.9994916319847107,
"pixel": 251.5,
"text": "20",
"value": 20.0
}
]
}
追加一条审查结论
选择“有效 KM”时,四边 ROI、四个坐标范围、Panel、终点和曲线数均为必填。
追加式审计历史
最新事件仅作为当前缓存;以下每一条既往结论都永久保留。
| 事件 | 时间 / 审查人 | 状态 | ROI | 坐标 | 说明 |
|---|---|---|---|---|---|
| #11p1-visual-axis-audit-v2 · frozen benchmark contact sheets + original images + RapidOCR re-audit | 2026-07-28T15:12:18+00:00Codex-assisted visual audit | valid_km | {'x0': 120, 'x1': 628, 'y0': 6, 'y1': 314} |
X 0.0–54.0 / Y 0.0–100.0 |
P1 冻结原图审查;RapidOCR 刻度重审 + 联系表视觉核验;ROI 四边按可见坐标轴框记录。 |
最近一次正式比较
Suite #3 · 2026-07-28T15:15:12+00:00
真值完整 117 / 120;通过 0;缺真值 0;无效案例 3。



